Adherence Watch: Patient Visibility Outside Traditional Channels: Do DTP and Cash-Pay Models Create Adherence Blind Spots?
As DTP and cash-pay access models grow, patients are moving beyond the claims and dispensing data hubs use to track adherence. Here’s what that means for patient support programs.
From Patient-Reported Outcomes to Personalized Outcomes: How the Patient’s Voice is Emerging in Drug Development
Drug development has moved from measuring disease to measuring how patients feel and function. The next question is whether we are measuring what matters most to each individual patient.
Inspection Readiness Is a Mindset, Not a Moment
Ask most people what inspection readiness means and you’ll hear about a scramble: pulling documents together, briefing colleagues, running mock inspections in the weeks before the real thing. That picture isn’t wrong, it’s just incomplete, and it puts the emphasis in the wrong place.
Beyond Static Reports: How Real-Time Safety Dashboards Are Changing Client Conversations
When the only view of the program is a static snapshot, the honest answer is often “we’ll know when the next report comes in.” That is the gap real-time dashboards close.
Don’t Search – Ask? A Smarter Way to Navigate Controlled Documents
The documentation has never been the problem. The problem is accessing the right part of it quickly enough to support day-to-day operations.
Summary and Key Takeaways from FDA’s September 2026 Public Hearing on Psychedelic Drugs
On September 14, 2026, FDA convened a Part 15 hearing to discuss “Considerations for Potential Future Therapeutic Use of Psychedelic Drugs.” The meeting was a compilation of 2 minute segments for 80 public commentators representing a diverse community of academia, patients, advocates, service providers, and industry.
The Physician Layer: Why Medical Oversight in PV is Non-Negotiable
Yes, automation can process volume. What it can’t do is exercise clinical judgment on a case that doesn’t fit the pattern, defend a causality assessment to a health authority inspector, or carry a program’s institutional history from one reviewer to the next. Those are not workflow steps. They’re physician functions.
Best Practices in Oncology Joint Clinical Assessment (JCA) Submissions Under the EU HTA Regulation
The first oncology JCA reports show that this new EU assessment process is anything but routine. Here’s what sponsors can learn from early submissions, and how to prepare for what’s ahead.
AI and Automation in Patient Services: A Strategic Guide to Using the Right Tool
The question for Patient Services leaders isn’t automation vs. AI. It’s knowing where each capability creates value, where it introduces risk, and how to build both into a stronger service model.
